Congenital isolated hyperinsulinism
ORPHA:657Clinical groupAutosomal dominant, Autosomal recessiveChildhood, Infancy, Neonatal
Эпидемиология8
| Тип оценки | Класс распространённости | Среднее (на 100к) | Регион | Квалификация |
|---|---|---|---|---|
| Prevalence at birth | 1-9 / 100 000 | 2.24 | Czech Republic | Value and class |
| Prevalence at birth | 1-9 / 100 000 | 5.25 | Japan | Value and class |
| Prevalence at birth | 1-9 / 100 000 | 3.52 | United Kingdom | Value and class |
| Prevalence at birth | 1-9 / 100 000 | 2 | Netherlands | Value and class |
| Prevalence at birth | 1-5 / 10 000 | 40 | Saudi Arabia | Value and class |
| Prevalence at birth | 1-9 / 100 000 | 3.67 | Worldwide | Value and class |
| Point prevalence | Unknown | — | Worldwide | Class only |
| Point prevalence | 1-5 / 10 000 | 23.2 | China | Value and class |
Лекарства и терапия
Источник: Open Targets Platform (в реальном времени)
Клинические исследования
Источник: ClinicalTrials.gov (в реальном времени)